1. Brown-Grant K: Extrathyroidal iodide concentrating mechanisms. Physiol Rev 4l:189-211, 1961.
2. Modan B, Mart H, Baidatz D: Radiation-induced head and neck tumors. Lancet 1:277-299, 1974.
3. Hall P, Boice JD, Berg G, Bjelkkengren G, Ericsson U-B, Hallquist A et al. Leukaemia incidence after iodine-131 exposure. Lancet 340:1-4, 1992.
5. Quimby EH, Feitelberg S, Gross W: Radioactive nuclides in medicine and biology (ed 3). Lea & Febiger, 1970.
6. MIRD: Dose estimate report no. 5: Summary of current radiation dose estimates to humans from 123I, 124I, 126I, 130I, 131I, and 132I as sodium iodide. J Nucl Med 16:857-860, 1975.
7. MIRD: Dose estimate report no. 8: Summary of current radiation dose estimates to normal humans from 99mTc as sodium pertechnetate. J Nucl Med 17:74-77, 1976.
8. Pittman JA Jr., Dailey GE III, Beschi RJ: Changing normal values for thyroidal radioiodine uptake. N Engl J Med 280:1431-1434, 1969.
9. Gluck FB, Nusynowitz ML, Plymate S: Chronic lymphocytic thyroiditis, thyrotoxicosis, and low radioactive iodine uptake: Report of four cases. N Engl J Med 293:624-628, 1975.
10. Savoie JC, Massin JP, Thomopoulos P, Leger F: Iodine-induced thyrotoxicosis in apparently normal thyroid glands. J Clin Endocrinol Metab 41:685-691, 1975.
11. Higgins HP, Ball D, Estham S: 20-min 99mTc thyroid uptake: A simplified method using the gamma camera. J Nucl Med 14:907-911, 1973.
12. Baschieri L, Benedetti G, deLuca F, Negri M: Evaluation and limitations of the perchlorate test in the study of thyroid function. J Clin Endocrinol Metab 23:786-791, 1963.
18. Chopra IJ, Fisher DA, Solomon DH, Beall GN: Thyroxine and triiodothyronine in the human thyroid. J Clin Endocrinol Metab 36:311-316, 1973.
19. Engler D, Burger AG: The deiodination of iodothyronines and of their derivatives in man. Endocr Rev 5:151-184, 1984.
20. Pittman CS, Shimizu T, Burger A, Chambers JB Jr.: The nondeiodinative pathways of thyroxine metabolism: 3,5,3',5'-tetraiodothyroacetic acid turnover in normal and fasting human subjects. J Clin Endocrinol Metab 50:712-716, 1980.
21. Gavin LA, Livermore BM, Cavalieri RR, al e: Serum concentration, metabolic clearance, and production rates of 3,5,3'-triiodothyroacetic acid in normal and athyreotic man. J Clin Endocrinol Metab 51:529-534, 1980.
22. Chopra IJ, Wu S-Y, Teco GNC, Santini F: A radioimmunoassay for measurement of 3,5,3'-triiodothyronine sulfate: Studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. 75:189-194, 1992.
23. deVijlder JJM, Veenboer GJM: Thyroid albumin originates from blood. Endocrinology 131:578-584, 1992.
24. Surks MI, Oppenheimer JH: Formation of iodoprotein during the peripheral metabolism of 3,5,3'-triiodo-L-thyroxine-125I in the euthyroid man and rat. J Clin Invest 48:685-695, 1969.
25. Refetoff S, Matalon R, Bigazzi M: Metabolism of L-thyroxine (T4) and L-triiodothyronine (T3) by human fibroblasts in tissue culture: Evidence for cellular binding proteins and conversion of T4 to T3. Endocrinology 91:934-947, 1972.
26. Koerner D, Surks MI, Oppenheimer JH: In vitro formation of apparent covalent complexes between L-triiodothyronine and plasma protein. J Clin Endocrinol Metab 36:239-245, 1973.
27. Trevorrow V: Studies on the nature of the iodine in blood. J Biol Chem 127:737-750, 1939.
28. Barker SB: Determination of protein-bound iodine. J Biol Chem 173:715-724, 1948.
29. Refetoff S: Principles of competitive binding assay and radioimmunoassay. A. Gottschalk and E. J. Potchen (eds), Diagnostic Nuclear Medicine (Golden's Diagnostic Radiology), Williams & Wilkins, Baltimore, pp. 215-236,1976.
31. O'Connor JF, Wu GY, Gallagher TF, Hellman L: The 24-hour plasma thyroxin profile in normal man. J Clin Endocrinol Metab 39:765-771, 1974.
32. Fang VS, Refetoff S: Radioimmunoassay for serum triiodothyronine: Evaluation of simple techniques to control interference from binding proteins. Clin Chem 20:1150-1154, 1974.
33. Larsen PR, Dockalova J, Sipula D, Wu FM: Immunoassay of thyroxine in unextracted human serum. J Clin Endocrinol Metab 37:117-182, 1973.
34. Sterling K, Milch PO: Thermal inactivation of thyroxine-binding globulin for direct radioimmunoassay of triiodothyronine in serum. J Clin Endocrinol Metab 38:866-875, 1974.
35. Mitsuma T, Nihei N, Gershengorn MC, Hollander CS: Serum triiodothyronine: Measurements in human serum by radioimmunoassay with corroboration by gas-liquid chromatography. J Clin Invest 50:2679-2688, 1971.
38. Ikekubo K, Konishi J, Endo K, et al: Anti-thyroxine and anti-triiodothyronine antibodies in three cases of Hashimoto's thyroiditis. Acta Endocrinol 89:557-566, 1978.
39. Sakata S, Nakamura S, Miura K: Autoantibodies against thyroid hormones or iodothyronine. Implications in diagnosis, thyroid function, treatment, and pathogenesis. Ann Intern Med 103:579-589, 1985.
40. Canadian Task Force on the periodic health examination. Periodic health examination, 1990 Update: 1. Early detection of hyperthyroidism and hypothyroidism in adults and screening of newborns for congenital hypothyroidism. J Can Med Assoc 142:955-961, 1990.
42. Schuurs AWM, Van Weemen BK: Enzyme-immunoassay. Clin Chim Acta 81:1-40, 1977.
43. Galen RS, Forman D: Enzyme immunoassay of serum thyroxine with AutoChemist" multichannel analyzer. Clin Chem 23:119-121, 1977.
44. Schall RF, Fraser AS, Hausen HW, al e: A sensitive manual enzyme immunoassay for thyroxine. Clin Chem 24:1801-1804, 1978.
45. Miyai K, Ishibashi K, Kawashima M: Enzyme immunoassay of thyroxine in serum and dried blood samples on filter paper. Endocrinol Jpn 27:375-380, 1980.
45a. Rongen HA, Hoetelmans RM, Bult A, van Bennekom: Chemiluminescence and immunoassays. J Pharmaceut Biomed Anal 12:433-62, 1994
45b Gonzalez RR, Robaina R, Rodriguez ME, BlancaS : An enzyme immunoassay for determining total thyroxine in human serum using an ultramicroanalytical system. Clin Chim Acta 197:159-170, 1991
50. Refetoff S: Inherited thyroxine-binding globulin (TBG) abnormalities in man. Endocr Rev 10:275-293, 1989.
51. Abuid J, Klein AH, Foley TP Jr., Larsen PR: Total and free triiodothyronine and thyroxine in early infancy. J Clin Endocrinol Metab 39:263-268, 1974.
52. Franklyn JA, Ramsden DB & Sheppard MC: The influence of age and sex on tests of thyroid function. Annal Clin Biochem 22:502-505, 1985.
53. Westgren U, Burger A, Ingemanssons S, Melander A, Tibblin S, Wahlin E: Blood levels of 3,5,3'-triiodothyronine and thyroxine: Differences between children, adults, and elderly subjects. Acta Med Scand 200:493-495, 1976.
56. DeCostre P, Buhler U, DeGroot LJ, Refetoff S: Diurnal rhythm in total serum thyroxine levels. Metabolism 20:782-791, 1971.
57. Bartalena L: Recent achievements in studies on thyroid hormone-binding proteins. Endocr Rev 11:47-64, 1990.
58. Stockigt JR, Topliss DJ, Barlow JW, White EL, Hurley DM, Taft P: Familial euthyroid thyroxine excess: An appropriate response to abnormal thyroxine binding associated with albumin. J Clin Endocrinol Metab 53:353-359, 1981.
59. Sunthornthepvarakul T, Angkeow P, Weiss RE, Hayashi Y, Refetoff S: A missense mutation in the albumin gene produces familial disalbuminemic hyperthyroxinemia in 8 unrelated families. Biochem Biophys Res Commun 202:781-787, 1994.
60. Sterling K, Refetoff S, Selenkow HA: T3 toxicosis: Thyrotoxicosis due to elevated serum triiodothyronine levels. JAMA 213:571-575, 1970.
61. Sterling K, Brenner MA, Newman ES, al e: The significance of triiodothyronine (T3) in maintenance of euthyroid status after treatment of hyperthyroidism. J Clin Endocrinol Metab 33:729-731, 1971.
62. Delange F, Camus M, Ermans AM: Circulating thyroid hormones in endemic goiter. J Clin Endocrinol Metab 34:891-895, 1972.
63. Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC: Thyroxine prescription in the community: serum TSH level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 43:107-109, 1993.
64. Saberi M, Utiger RD: Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J Clin Endocrinol Metab 39:923-927, 1974.
67. Olsen T, Laurberg P, Weeke J: Low serum triiodothyronine and high serum reverse triiodothyronine in old age: An effect of disease not age. J Clin Endocrinol Metab 47:1111-1115, 1978.
68. Welle S, O'Conell M, Danforth D Jr., Campbell R: Decreased free fraction of serum thyroid hormones during carbohydrate over-feeding. Metabolism 33:837-839, 1984.
69. Portnay GI, O'Brian JT, Bush J, al e: The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab 39:191-194, 1974.
70. Azizi F: Effect of dietary composition on fasting-induced changes in serum thyroidhormones and thyrotropin. Metabolism 27:935-942, 1978.
71. Scriba PC, Bauer M, Emmert D, al e: Effects of obesity, total fasting and re-alimentation of L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding gloublin (CBG), transferrin, a2-haptoglobin and complement C'3 in serum. Acta Endocrinol 91:629-643, 1979.
72. Larsen PR: Triiodothyronine. Review of recent studies of its physiology and pathophysiology in man. Metabolism 21:1073-1092, 1972.
75. Rösler A, Litvin Y, Hage C, Gross J, Cerasi E: Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine. J Clin Endocrinol Metab 54:76-82, 1982.
76. Maxon HR, Burman KD, Premachandra BN, et al: Familial elevation of total and free thyroxine in healthy, euthyroid subjects without detectable binding protein abnormalities. Acta Endocrinol 100:224-230, 1982.
77. Chopra IJ, Williams DE, Orgiazzi J, Solomon DH: Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3',5-triiodothyronine (T3). J Clin Endocrinol Metab 41:911-920, 1975.
78. Cavalieri RR, Sung LC, Becker CE: Effects of phenobarbital on thyroxine and triiodothyronine kinetics in Graves' disease. J Clin Endocrinol Metab37 308-316:1973.
79. Davies PH, Franklyn JA: Effects of drugs on tests of thyroid function. Eur J Clin Pharmacol 40:439-451, 1991.
80. Busnardo B, Vangelista R, Girelli ME, al. e: TSH levels and TSH response to TRH as a guide to the replacement treatment of patients with thyroid carcinoma. J Clin Endocrinol Metab 42:901-906, 1976.
83. Refetoff S, Hagen S, Selenkow HA: Estimation of the T4 binding capacity of serum TBG and TBPA by a single T4 load ion exchange resin method. J Nucl Med 13:2-12, 1972.
87. Miyai K, Ito M, Hata N: Enzyme immunoassay of thyroxine-binding globulin. Clin Chem 28:2408-2411, 1982.
88. Refetoff S, Murata Y, Vassart G, Chandramouli V, Marshall JS: Radioimmunoassays specific for the tertiary and primary structures of thyroxine-binding globulin (TBG): Measurement of denatured TBG in serum. J Clin Endocrinol Metab 59:269-277, 1984.
89. Freeman T, Pearson JD: The use of quantitative immunoelectrophoresis to investigate thyroxine-binding human serum proteins. Clin Cheim Acta 26:365-368, 1969.
90. Nielsen HG, Buus O, Weeke B: A rapid determination of thyroxine-binding globulin in human serum by means of the Laurell Rocket immunoelectrophoresis. Clin Chim Acta 36:133-138, 1972.
91. Mancini G, Carbonara AO, Heremans JF: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235-254, 1965.
92. Chopra IJ, Solomon DH, Ho RS: Competitive ligand-binding assay for measurement of thyroxine-binding globulin (TBG). J Clin Endocrinol Metab 35:565-573, 1972.
93. Marshall JS, Levy RP, Steinberg AG: Human thyroxine-binding globulin deficiency: A genetic study. N Engl J Med 274:1469-1473, 1966.
94. Ekins R: Measurement of free hormones in blood. Endocrine Rev 11:5-6, 1990.
97. Nelson JC, Tomel RT: Direct determination of free thyroxin in undiluted serum by equilibrium dialysis/radioimmunoassay. Clin Chem 34:1737-1744, 1988.
98. Surks MI, Hupart KH, Pan C, Shapiro LE: Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis. J Clin Endocrinol Metab 67:1031-1039, 1988.
99. Melmed S, Geola FL, Reed AW, al e: A comparison of methods for assessing thyroid function in non-thyroidal illness. J Clin Endocrinol Metab 54:300-306, 1982.
100. Wong TK, Pekary E, Hoo GS, Bradley ME, Hershman JM: Comparison of methods for measuring free thyroxin in nonthyroidal illness. Clin Chem 38:720-724, 1992.
101. Chopra IJ, Chopra U, Smith SR, al e: Reciprocal changes in serum concentration of 3,3',5'-triiodothyronine (reverse T3) and 3,3',5-triiodothyronine (T3) in systemic illnesses. J Clin Endocrinol Metab 41:1043-1049, 1975.
102. Oppenheimer JH, Squef R, Surks MI, Hauer H: Binding of thyroxine by serum proteins evaluated by equilibrium dialysis and electrophoretic techniques. Alterations in non-thyroidal illness. J Clin Invest 42:1769-1782, 1963.
103. Snyder SM, Cavalieri RR, Ingbar SH: Simultaneous measurement of percentage free thyroxine and triiodothyronine: Comparison of equilibrium dialysis and Sephadex chromatography. J Nucl Med 17:660-664, 1976.
104. Nelson JC, Bruce WR, Pandian MR: Dependence of free thyroxine estimates obtained with equilibrium tracer dialysis on the concentration of thyroxine-binding gloublin. Clin Chem 38:1294-1300, 1992.
104a Nelson JC, Weiss R, Wilcox RB: Underestimates of serum free T4 concentrations by free T4 immunoassays. J Clin Endocrinol Metab 79:76-79, 1994
104b Nelson JC, Nayak SS, Wilcox RB: Variable underestimates of serum free T4 immunoassays of free t4 concentrations in simple solutions. J Clin Endocrinol Metab 79:1373-1375, 1994
105c Faber J, Waetjen I, Siersbaek-Nielsen K: Free T4 measured in undiluted serum by dialysis and ultrafiltration: effects of non-thyroidal illness and an acute load of salicylate or heparin. Clin Chim Acta 223:159-167, 1993
105. Van der Sluijs Veer G, Vermes I, Bonte HA, Hoorn RKJ: Temperature effects on free-thyroxine measurements: Analytical and clinical consequences. Clin Chem 38:1327-1331, 1992.
106. Larsen PR, Alexander NM, Chopra IJ, et al: Revised nomenclature for test of thyroid hormones and thyroid-related proteins in serum. Clin Chem 33:2114-2116, 1987.
107. Felicetta JV, Green WL, Mass LB, al e: Thyroid function and lipids in patients with chronic liver disease treated by hemodialysis with comments on the free thyroxine index. Metabolism 28:756-763, 1979.
109. Glinoer D, Fernandez-Deville M, Ermans AM: Use of direct thyroxine-binding gloublin measurement in the evaluation of thyroid function. J Endocrinol Invest 1:329-335, 1978.
110. Attwood EC: The T3/TBG ratio and the biochemical investigation of thyrotoxicosis. Clin Biochem 12:88-92, 1979.
111. Nuutila P, Koskinen P, Irjala K, et al: Two new two-step immunoassays for free thyroxin evaluated: Solid-phase radioimmunoassay and time-resolved fluoroimmunoassay. Clin Chem 36:1355-1360, 1990.
112. Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA: American Thyroid Association assessment of current free thyroid hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem 37:2002-2008, 1991.
113. Wilkins TA, Midgley JEM, Barron N: Comprehensive study of a thyroxin-analog-based assay for free thyroxin ("Amerlex FT4"). Clin Chem 31:1644-1653, 1985.
113a Stockigt JR, Stevens V, White E, Barlow JW: Unbound analog radioimmunoassays for free thyroxin measure the albumen-bound hormone fraction. Clin Chem 29:1408-10, 1983.
113b Christofides ND, Sheehan CP: Enhanced chemiluminescence labeled-antibody immunoassay (Amerlite-MAB) for free thyroxine: design, development and technical validation. Clin Chem 41: 17-23, 1995
113c Christofides ND, Sheehan CP: Multicenter evaluation of enhanced chemiluminescence labeled-antibody immunoassay (Amerlite-MAB) for free thyroxine. Clin Chem 41: 24-31, 1995
114. John R: Autoantibodies to thyroxin and interference with free-thyroxin assay. Clin Chem 29:581-582, 1983.
116. Sarne DH, Refetoff S, Murata Y, Dick M, Watson F: Variant thyroxine-binding globulin in serum of Australian Aborigines. A comparison with familial TBG deficiency in Caucasians and American Blacks. J Endocrinol Invest 8:217-224, 1985.
116a Samuels MH, Pillote K, Asher D et al. Variable effects of nonsteroidal antiinflammatory agents on thyroid test results. J Clin Endocrinol Metab 2003; 88: 5710-6.
117. Murata Y, Refetoff S, Sarne DH, Dick M, Watson F: Variant thyroxine-binding globulin in serum of Australian Aborigines: Its physical, chemical and biological properties. J Endocrinol Invest 8:225-232, 1985.
119. Kaptein EM, Macintyre SS, Weiner JM, al e: Free thyroxine estimates in nonthyroidal illness: Comparison of eight methods. J Clin Endocrinol Metab 52:1073-1077, 1981.
120. Lehotay DC, Weight CW, Seltman JH, al e: Free thyroxin: A comparison of direct and indirect methods and their diagnostic usefulness in nonthyroidal illness. Clin Chem 28:1826-1829, 1982.
121. Oppenheimer JH, Schwartz HL, Mariash CN, Kaiser FE: Evidence for a factor in the sera of patients with nonthyroidal illness which inhibits iodothyronine binding by solid matrices, serum proteins, and rat hepatocytes. J Clin Endocrinol Metab 54:757-766, 1982.
122. Woeber KA, Maddux BA: Thyroid hormone binding in nonthyroidal illness. Metabolism 30:412-416, 1981.
123. Chopra IJ, Solomon DH, Teco GNC, Eisenberg JB: An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science 215:407-409, 1982.
124. Chopra IJ, Chua Teco GN, Mead JF, al. e: Relationship between serum free fatty acids and thyroid hormone binding inhibitor in nonthyroidal illnesses. J Clin Endocrinol Metab 60:980-984, 1985.
126. Chopra IJ: An assessment of daily production and significance of thyroidal secretion of 3,3',5'-triiodothyronine (reverse T3) in man. J Clin Invest 58:32-40, 1976.
127. Nicod P, Burger A, Staeheli V, Vallotton MB: A radioimmunoassay for 3,3',5'-triiodo-L-thyronine in unextracted serum: Method and clinical results. J Clin Endocrinol Metab 42:823-829, 1976.
128. Chopra IJ: A radioimmunoassay for measurement of 3,3',5'-triiodothyronine (reverse T3). J Clin Invest 54:583-592, 1974.
129. O'Connell M, Robbins DC, Bogardus C, al. e: The interaction of free fatty acids in radioimmunoassays for reverse triiodothyronine. J Clin Endocrinol Metab 55:577-582, 1982.
132. Weiss RE, Angkeow P, Sunthornthepvarakul T, et al: Linkage of familial dysalbuminemic hyperthyroxinemia to the albumin gene in a large Amish family. J Clin Endocrinol Metab 80:1995.
133. Chopra IJ: A radioimmunoassay for measurement of 3'-monoiodothyronine. J Clin Endocrinol Metab 51:117-123, 1980.
134. Chopra IJ, Sack J, Fisher DA: Circulating 3,3',5'-triiodothyronine (reverse T3) in the human newborn. J Clin Invest 55:1137-1141, 1975.
135. Engler D, Markelbach U, Steiger G, Burger AG: The monodeiodination of triiodothyronine and reverse triiodothyronine in man: A quantitative evaluation of the pathway by the useof turnover rate techniques. J Clin Endocrinol Metab 58:49-61, 1984.
136. Pangaro L, Burman KD, Wartofsky L, al. e: Radioimmunoassay for 3,5-diiodothyronine and evidence for dependence on conversion from 3,5,3'-triiodothyronine. J Clin Endocrinol Metab 50:1075-1081, 1980.
137. Faber J, Kirkegaard C, Lumholtz IB, al. e: Measurements of serum 3',5'-diiodothyronine and 3,3'-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: Studies of 3',5'-diiodothyronine metabolism. J Clin Endocrinol Metab 48:611-617, 1979.
138. Geola F, Chopra IJ, Geffner DL: Patterns of 3,3',5'-triiodothyronine monodeiodination in hypothyroidism and nonthyroidal illnesses. J Clin Endocrinol Metab 50:336-340, 1980.
139. Chopra IJ, Geola F, Solomon DH, Maciel RMB: 3',5'-diiodothyroxine in health and disease: Studies by a radioimmunoassay. J Clin Endocrinol Metab 47:1198-1207, 1978.
140. Burman KD, Wright FD, Smallridge RC, al. e: A radioimmunoassay for 3',5'-diiodothyronine. J Clin Endocrinol Metab 47:1059-1064, 1978.
141. Jaedig S, Faber J: The effect of starvation and refeeding with oral versus intravenous glucose on serum 3,5-,3,3'- and 3',5'-diiodothyronine and 3'-monoiodothyronine. Acta Endocrinol 100:388-392, 1982.
142. Smallridge RC, Wartofsky L, Green BJ, al. e: 3'-L-monoiodothyronine: Development of a radioimmunoassay and demonstration of in vivo conversion from 3',5'-diiodothyronine. J Clin Endocrinol Metab 48:32-36, 1979.
143. Corcoran JM, Eastman CJ: Radioimmunoassay of 3-L-monoiodothyronine: Application in normal human physiology and thyroid disease. J Clin Endocrinol Metab 57:66-70, 1983.
144. Nakamura Y, Chopra IJ, Solomon DH: An assessment of the concentration of acetic acid and proprionic acid derivatives of 3,5,3'-triiodothyronine in human serum. J Clin Endocrinol Metab 46:91-97, 1978.
145. Burger A, Suter P, Nicod P, al. e: Reduced active thyroid hormone levels in acute illness. Lancet 1:163-655, 1976.
146. Pittman CS, Suda AK, Chambers JB Jr., al. e: Abnormalities of thyroid hormone turnover in patients with diabetes mellitus before and after insulin therapy. J Clin Endocrinol Metab 48:854-860, 1979.
147. Dlott RS, LoPresti JS, Nicoloff JT: Evidence that triiodoacetate (TRIAC) is the autocrine thyroid hormone in man. Thyroid 2(Suppl):S-94, 1992.
148. Nelson JC, Weiss RM, Lewis JE, al. e: A multiple ligand-binding radioimmunoassay of diiodothyrosine. J Clin Invest 53:416-422, 1974.
149. Nelson JC, Lewis JE: Radioimmunoassay of iodotyrosines. G. E. Abraham (eds), Handbook of Radioimmunoassay, Marcel Dekker, New York, pp. p 705,1979.
150. Meinhold H, Beckert A, Wenzel W: Circulating diiodotyrosine: Studies of its serum concentration, source, and turnover using radioimmunoassay after immunoextraction. J Clin Endocrinol Metab 53:1171-1178, 1981.
151. Van Herle AJ, Uller RP, Matthews NL, Brown J: Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest 52:1320-1327, 1973.
151a Spencer CA, Takeuchi M, Kazarosyan M: Current status and performance goals for serum thyroglobulin assays. Clin Chem 42:164-173, 1996
151b Marquet PY, Daver A, Sapin R et al. Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodies. Clin Chem 42: 258-262, 1996
151c Erali M, Bigelow RB, Meikle AW. ELISA for thyroglobulin in serum: recovery studies to evaluate autoantibody interference and relaibility of thyroglobulin values. Clin Chem 42: 766-770, 1996
151d Dai J, Dent W, Atkinson JW, Cox JG, Dembinski TC. Comparison of three immunoassay kits for serum thryoglobulin in patients with thyroid cancer. Clin Biochem 29:461-465, 1996
152. Spencer CA, Takeuchi M, Kazarosyan M, al. e: Serum thryoglobulin autoantibodies:prevalence, influence on serum thryoglobulin measurement, and prognostic significance in patients with differentiated thryoid carcinoma. J Clin Endocrinol Metab 83: 1121-27, 1998.
152a Spencer CA, Wang CC. Thyroglobulin measurement. Techniques, clinical benefits and pitfalls. Endocrinol Metab Clin North Am 24:841-63, 1995
153. Ozata M, Suzuki S, Miyamoto T, al e.: Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J Clin Endocrinol Metab 79:98-105, 1994.
154. Pacini F, Pinchera A, Giani C, Grasso L, Dover F, Baschieri L: Serum thyroglobulin in thyroid carcinoma and other thyroid disorders. J Endocrinol Invest 3:283-292, 1980.
155. Black EG, Cassoni A, Gimlette TMD, al. e: Serum thyroglobulin in thyroid cancer. Br Med J 3:443-445, 1981.
156. Pezzino V, Filetti S, Belfiore A, al. e: Serum thyroglobulin levels in the newborn. J Clin Endocrinol Metab 52:364-366, 1981.
157. Penny R, Spencer CA, Frasier D, Nicoloff JT: Thyroid-stimulating hormone and thyroglobulin levels decrease with chronological age in children and adolescents. J Clin Endocrinol Metab 56:177-180, 1983.
158. Refetoff S, Lever EG: The value of serum thyroglobulin measurement in clinical practice. JAMA 250:2352-2357, 1983.
159. Izumi M, Kubo I, Taura M, al. e: Kinetic study of immunoreactive human thyroglobulin. J Clin Endocrinol Metab 62:400-412, 1986.
160. Uller RP, Van Herle AJ, Chopra IJ: Comparison of alterations in circulating thyroglobulin, triiodothyronine and thyroxine in response to exogenous (bovine) and endogenous (human) thyrotropin. J Clin Endocrinol Metab 37:741-745, 1973.
161. Lever EG, Refetoff S, Scherberg NH, Carr K: The influence of percutaneous fine needle aspiration on serum thyroglobulin. J Clin Endocrinol Metab 56:26-29, 1983.
162. Uller RP, Van Herle AJ: Effect of therapy on serum thyroglobulin levels in patients with Graves' disease. J Clin Endocrinol Metab 46:747-755, 1978.
163. Smallridge RC, DeKeyser FM, Van Herle AJ, al. e: Thyroid iodine content and serum thyroglobulin: Clues to the national history of destruction-induced thyroiditis. J Clin Endocrinol Metab 62:1213-1219, 1986.
164. Mariotti S, Martino E, Cupini C, al. e: Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia. N Engl J Med 307:410-412, 1982.
165. Van Herle AJ, Uller RP: Elevated serum thyroglobulin: A marker of metastases in differentiated thyroid carcinoma. J Clin Invest 56:272-277, 1975.
166. Schneider AB, Line BR, Goldman JM, Robbins J: Sequential serum thyroglobulin determinations, 131I scans, and 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J Clin Endocrinol Metab 53:1199-1206, 1981.
167. Colacchio TA, LoGerfo P, Colacchio DA, Feind C: Radioiodine total body scan versus serum thyroglobulin levels in follow-up of patients with thyroid cancer. Surgery 91:42-45, 1982.
168. Black EG, Sheppard MC: Serum thyroglobulin measurements in thyroid cancer: evaluation of "false" positive results. Clin Endocrinol (Oxf) 35:519-20, 1991.
169. Kawamura S, Kishino B, Tajima K, al. e: Serum thyroglobulin changes in patients with Graves' disease treated with long term antithyroid drug therapy. J Clin Endocrinol Metab 56:507-512, 1983.
170. Black EG, Bodden SJ, Hulse JA, Hoffenberg R: Serum thyroglobulin in normal and hypothyroid neonates. Clin Endocrinol 16:267-274, 1982.
171. Heinze HJ, Shulman DI, Diamond FB Jr., Bercu BB: Spectrum of serum thyroglobulin elevation in congenital thyroid disorders. Thyroid 3:37-40, 1993.
172. Czernichow P, Schlumberger M, Pomarede R, Fragu P: Plasma thyroglobulin measurements help determine the type of thyroid defect in congenital hypothyroidism. J Clin Endocrinol Metab 56:242, 1983.
173. Burke CW, Shakespear RA, Fraser TR: Measurement of thyroxine and triiodothyronine in human urine. Lancet 2:1177-1179, 1972.
174. Chan V, Landon J: Urinary thyroxine excretion as index of thyroid function. Lancet 1:4-6, 1972.
175. Chan V, Besser GM, Landon J, Ekins RP: Urinary tri-iodothyronine excretion as index of thyroid function. Lancet 2:253-256, 1972.
176. Burke CW, Shakespear RA: Triiodothyronine and thyroxine in urine. II. Renal handling, and effect of urinary protein. J Clin Endocrinol Metab 42:504-513, 1976.
177. Sack J, Fisher DA, Hobel CJ, Lam R: Thyroxine in human amniotic fluid. J Pediatr 87:364-368, 1975.
178. Chopra IJ, Crandall BF: Thyroid hormones and thyrotropin in amniotic fluid. N Engl J Med 293:740-743, 1975.
179. Burman KD, Read J, Dimond RC, al. e: Measurement of 3,3',5'-triiodothyronine (reverse T3), 3,3'-L-diiodothyronine, T3, and T4 in human amniotic fluid and in cord and maternal serum. J Clin Endocrinol Metab 43:1351-1359, 1976.
180. Siersbaek-Nielsen K, Hansen JM: Tyrosine and free thyroxine in cerebrospinal fluid in thyroid disease. Acta Endocrinol 64:126-132, 1970.
181. Hagen GA, Elliott WJ: Transport of thyroid hormones in serum and cerebrospinal fluid. J Clin Endocrinol Metab 37:415-422, 1973.
182. Nishikawa M, Inada M, Naito K, al. e: 3,3',5'-triiodothyronine (reverse T3) in human cerebrospinal fluid. J Clin Endocrinol Metab 53:1030-1035, 1981.
183. Mallol J, Obregón MJ, Morreale de Escobar G: Analytical artifacts in radioimmunoassay of L-thyroxin in human milk. Clin Chem 28:1277-1282, 1982.
184. Varma SK, Collins M, Row A, al. e: Thyroxine, tri-iodothyronine, and reverse tri-iodothyronine concentrations in human milk. J Pediatr 93:803-806, 1978.
185. Jansson L, Ivarsson S, Larsson I, Ekman R: Tri-iodothyronine and thyroxine in human milk. Acta Paediatr Scand 72:703-705, 1983.
186. Riad-Fahmy D, Read GF, Walker RF, Griffiths K: Steroids in saliva for assessing endocrine function. Endocr Rev 3:367-395, 1982.
187. Elson MK, Morley JE, Shafer RB: Salivary thyroxine as an estimate of free thyroxine: Concise communication. J Nucl Med 24:700-702, 1983.
188. Reichlin S, Bollinger J, Nejad I, Sullivan P: Tissue thyroid hormone concentration of rat and man determined by radioimmunoassay: Biologic significance. Mt Sinai J Med 40:502-510, 1973.
189. Ochi Y, Hachiya T, Yoshimura M, al. e: Determination of triiodothyronine in red blood cells by radioimmunoassay. Endocrinol Jpn 23:207-213, 1976.
190. Lim VS, Zavata DC, Flanigan MJ, Freeman RM: Basal oxygen uptake: A new technique for an old test. J Clin Endocrinol Metab 62:863-868, 1986.
191. Becker DV: Metabolic indices. S. C. Werner and S. H. Ingbar (eds), The Thyroid: A Fundamental and Clinical Text., Harper & Row, New York, pp. 524-533,1971.
192. Waal-Manning HJ: Effect of propranolol on the duration of the Achiles tendon reflex. Clin Pharmacol Ther 10:199-206, 1969.
193. Rodbard D, Fujita T, Rodbard S: Estimation of thyroid function by timing the arterial sounds. JAMA 2010:884-887, 1967.
194. Nuutila P, Irjala K, Saraste M, Seppälä P, Viikari J: Cardiac systolic time intervals and thyroid hormone levels during treatment of hypothyroidism. Scand J Clin Lab Invest 52:467-477, 1992.
195. Lewis BS, Ehrenfeld EN, Lewis N, Gotsman MS: Echocardiographic LV function in thyrotoxicosis. Am Heart J 97:460-468, 1979.
196. Tseug KH, Walfish PG, Persand JA, Gilbert BW: Concurrent aortic and mitral valve echocardiography permits mesurements of systolic time intervals as an index of peripheral tissue thyroid functional status. 69:633-638, 1989.
197. Vesell ES, Shapiro JR, Passananti GT, al. e: Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction. Clin Pharmacol Ther 17:48-56, 1975.
198. Brunk SF, Combs SP, Miller JD, al. e: Effects of hypothyroidism and hyperthyroidism on dipyrone metabolism in man. J Clin Pharmacol 14:271-279, 1974.
199. Kekki M: Serum protein turnover in experimental hypo- and hyperthyroidism. Acta Endocrinol suppl. 91:1-139, 1964.
200. Walton KW, Scott PJ, Dykes PW, Davies JWL: The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131I-low-density lipoproteins in hypothyroidism and thyrotoxicosis. Clin Sci 29:217-238, 1965.
201. Hellman L, Bradlow HL, Zumoff B, Gallagher TF: The influence of thyroid hormone on hydrocortisone production and metabolism. J Clin Endocrinol Metab 21:1231-1247, 1961.
202. Gallagher TF, Hellman L, Finkelstein J, al. e: Hyperthyroidism and cortisol secretion in man. J Clin Endocrinol Metab 34:919-927, 1972.
203. Kiely JM, Purnell DC, Owen CA Jr.: Erythrokinetics in myxedema. Ann Intern Med 67:533-538, 1967.
204. Das KC, Mukherjee M, Sarkar TK, al. e: Erythropoiesis and erythropoietin in hypo- and hyperthyroidism. J Clin Endocrinol Metab 40:211-220, 1975.
205. Rivlin RS, Melmon KL, Sjoerdsma A: An oral tyrosine tolerance test in thyrotoxicosis and myxedema. N Engl J Med 272:1143-1148, 1965.
206. Bélanger R, Chandramohan N, Misbin R, Rivlin RS: Tyrosine and glutamic acid in plasma and urine of patients with altered thyroid function. Metabolism 21:855-865, 1972.
207. Lamberg BA, Gräsbeck R: The serum protein pattern in disorders of thyroid function. Acta Endocrinol 19:91-100, 1955.
208. Anderson DC: Sex-hormone-binding globulin. Clin Endocrinol 3:69-96, 1974.
209. DeNayer P, Lambot MP, Desmons MC, Rennotte B, Malvaux P, Beckers C: Sex hormone-binding protein in hypothyroxinemic patients: a discriminator for thyroid status in thyroid hormone resistance and familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab 62:1309-1312, 1986.
210. Macaron CI, Macaron ZG: Increased serum ferritin levels in hyperthyroidism. Ann Intern Med 96:617-618, 1982.
211. Takamatsu J, Majima M, Miki K, Kuma K, Mozai T: Serum ferritin as a marker of thyroid hormone action on peripheral tissues. J Clin Endocrinol Metab 61:672-676, 1985.
212. Graninger W, Pirich KR, Speiser W, al. e: Effect of thyroid hormones on plasma protein concentration in man. J Clin Endocrinol Metab 63:407-411, 1986.
213. Oppenheimer JH: Role of plasma proteins in the binding, distribution, and metabolism of the thyroid hormones. N Engl J Med 278:1153-1162, 1968.
214. Shah JH, Cechio GM: Hypoinsulinemia of hypothyroidism. Arch Intern Med 132:657-661, 1973.
215. Levy LJ, Adesman JJ, Spergel G: Studies on the carbohydrate and lipid metabolism in thyroid disease: Effects of glucagon. J Clin Endocrinol Metab 30:372-379, 1970.
216. Chopra IJ, Tulchinsky D: Status of estrogen-androgen balance in hyperthyroid men with Graves' disease. J Clin Endocrinol Metab 38:269-277, 1974.
217. Seino Y, Matsukura S, Miyamoto Y, al. e: Hypergastrinemia in hyperthyroidism. J Clin Endocrinol Metab 43:852-855, 1976.
218. Bouillon R, DeMoor P: Parathyroid function in patients with hyper- or hypothyroidism. J Clin Endocrinol Metab 38:999-1004, 1974.
219. Castro JH, Genuth SM, Klein L: Comparative response to parathyroid hormone in hyperthyroidism and hypothyroidism. Metabolism 24:839-848, 1975.
220. Kojima N, Sakata S, Nakamura S, et al: Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis. J Endocrinol Invest 15:491-496, 1992.
221. Body JJ, Demeester-Mirkine N, Borkowski A, al. e: Calcitonin deficiency in primary hypothyroidism. J Clin Endocrinol Metab 62:700-703, 1986.
222. Hauger-Klevene JH, Brown H, Zavaleta J: Plasma renin activity in hyper- and hypothyroidism: Effect of adrenergic blocking agents. J Clin Endocrinol Metab 34:625-629, 1972.
223. Ogihara T, Yamamoto T, Miyai K, Kumahara Y: Plasma renin activity and aldosterone concentration of patients with hyperthyroidism and hypothyroidism. Endocrinol Jpn 20:433-438, 1973.
224. Stoffer SS, Jiang NS, Gorman CA, Pikler GM: Plasma catecholamines in hypothyroidism and hyperthyroidism. J Clin Endocrinol Metab 36:587-589, 1973.
225. Christensen NJ: Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema. Clin Sci Mol Med 45:163-171, 1973.
226. Zimmerman RS, Gharib H, Zimmerman D, al. e: Atrial naturetic peptide in hypothyroidism. J Clin Endocrinol Metab 64:353-355, 1987.
227. Rolandi E, Santaniello B, Bagnasco M, et al: Thyroid hormones and atrial natriuretic hormone secretion: Study in hyper- and hypothyroid patients. Acta Endocrinol 127:23-26, 1992.
228. Distiller LA, Sagel J, Morley JE: Assessment of pituitary gonadotropin reserve using luteinizing hormone-releasing hormone (LRH) in states of altered thyroid function. J Clin Endocrinol Metab 40:512-515, 1975.
229. Refetoff S, Fang VS, Rapoport B, Friesen HG: Interrelationships in the regulation of TSH and prolactin secretion in man: Effects of L-DOPA, TRH and thyroid hormone in various combinations. J Clin Endocrinol Metab 38:450-457, 1974.
230. Honbo KS, Van Herle AJ, Kellett KA: Serum prolactin levels in untreated primary hypothyroidism. Am J Med 64:782-787, 1978.
231. Brauman H, Corvilain J: Growth hormone response to hypoglycemia in myxedema. J Clin Endocrinol Metab 28:301-304, 1968.
232. Rosenfield PS, Wool MS, Danforth E Jr.: Growth hormone response to insulin-induced hypoglycemia in thyrotoxicosis. J Clin Endocrinol Metab 29:777-780, 1969.
233. Hamada N, Uoi K, Nishizawa Y, al. e: Increase of serum GH concentration following TRH injection in patients with primary hypothyroidism. Endocrinol Jpn 23:5-10, 1976.
234. Kung AEC, Hui WM, Ng ESK: Serum and plasma epidermal growth factor in thyroid disorders. Acta Endocrinol 127:52-57, 1992.
235. Graig FA, Smith JC: Serum creatine phosphokinase activity in altered thyroid states. J Clin Endocrinol Metab 25:723-731, 1965.
236. Fleisher GA, McConahey WM, Pankow M: Serum creatine kinase, lactic dehydrogenase, and glutamic-oxalacetic transminase in thyroid diseases and pregnancy. Mayo Clin Proc 40:300-311, 1965.
237. Doran GR, Wilkinson JH: Serum creatine kinase and adenylate kinase in thyroid disease. Clin Chim Acta 35:115-119, 1971.
238. Stolk JM, Hurst JH, Nisula BC: The inverse relationship between serum dopamine-ß-hydroxylase activity and thyroid function. J Clin Endocrinol Metab 51:259-264, 1980.
239. Talbot NB, Hoeffel G, Shwachman H, Tuohy EL: Serum phosphatase as an aid in the diagnosis of cretinism and juvenile hypothyroidism. Am J Dis Child 62:273-278, 1941.
240. Lieberthal AS, Benson SG', Klitgaard HM: Serum malic dehydrogenase in thyroid disease. J Clin Endocrinol Metab 23:211-214, 1963.
241. Yotsumuto H, Imai Y, Kuzuya N, al. e: Increased levels of serum angiotensin-converting enzyme activity in hyperthyroidism. Ann Intern Med 96:326-328, 1982.
242. Gow SMG, Caldwell G, Toft AD, al. e: Relationship between pituitary and other target organ responsiveness in thyroid patients receiving thyroxine replacement. J Clin Endocrinol Metab 64:364-370, 1987.
243. Beckett GJ, Kellett HA, Gow SM, Hussey AJ, Hayes JD, Toft AD: Elevated plasma glutathione S-transferase concentrations in hyperthyroidism and in hypothyroid patients receiving thyroxine replacement: Evidence for hepatic damage. Br Med J 2:427-429, 1985.
244. Ogura F, Morii H, Ohmo M, al. e: Serum coenzyme Q10 levels in thyroid disorders. Horm Metab Res 12:537-540, 1980.
245. Bouillon R, Muls E, DeMoor P: Influence of thyroid function on the serum concentration of 1,25-dihydroxy vitamin D3. J Clin Endocrinol Metab 51:793-796, 1980.
246. Walton KW, Campbell DA, Tonks EL: The significance of alterations in serum lipids in thyroid function. I. The relation between serum lipoproteins, carotenoids, and vitamin A in hypothyroidism and thyrotoxicosis. Clin Sci 29:199-215, 1965.
247. Karlberg BE, Henriksson KG, Andersson RGG: Cyclic adenosine 3',5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism. J Clin Endocrinol Metab 39:96-101, 1974.
248. Peracchi M, Bamonti-Catena F, Lombardi L, al. e: Plasma and urine cyclic nucleotide levels in patients with hyperthyroidism and hypothyroidism. J Endocrinol Invest 6:173-177, 1983.
249. Rivlin RS, Wagner HN Jr.: Anemia in hyperthyroidism. Ann Intern Med 70:507-516, 1969.
250. Feldman DL, Goldberg WM: Hyperthyroidism with periodic paralysis. Can Med Assoc J 101:667-671, 1969.
251. Pettinger WA, Talner L, Ferris TF: Inappropriate secretion of antidiuretic hormone due to myxedema. N Engl J Med 272:362-364, 1965.
252. Jones JE, Deser PC, Shane SR, Flink EB: Magnesium metabolism in hyperthyroidism and hypothyroidism. J Clin Invest 45:891-900, 1966.
253. Baxter JD, Bondy PK: Hypercalcemia of thyrotoxicosis. Ann Intern Med 65:429-442, 1966.
254. Weldon AP, Danks DM: Congenital hypothyroidism and neonatal jaundice. Arch Dis Child 47:469-471, 1972.
255. Greenberger NJ, Milligan FD, DeGroot LJ, Isselbacher KJ: Jaundice and thyrotoxicosis in the absence of congestive heart failure: A study of four cases. Am J Med 36:840-846, 1964.
256. Kuhlbäch B: Creatine and creatinine metabolism in thyrotoxicosis and hypothyroidism. Acta Med Scand suppl. 331:1-70, 1957.
257. Adlkofer F, Armbrecht U, Schleusener H: Plasma lecithin: Cholesterol acyltransferase activity in hypo- and hyperthyroidism. Horm Metab Res 6:142-146, 1974.
258. Pykälistö O, Goldberg AP, Brunzell JD: Reversal of decreased human adipose tissue lipoprotein lipase and hypertriglyceridemia after treatment of hypothyroidism. J Clin Endocrinol Metab 43:591-600, 1976.
259. De Bruin TWA, Van Barlingen H, Van Linde-Sibenius Trip M, Van Vuurst De Vries A-RR, Akveld MJ, Erkelens DW: Lipoprotein (a) and Apolipoprotein B Plasma Concentrations in Hypothyroid, Euthyroid, and Hyperthyroid Subjects. J Clin Endocrinol Metab 76:121-126, 1993.
260. Inui T, Ochi Y, Chen W, Nakajima Y, Kajita Y: Increased serum concentration of type IV collagen peptide and type III collagen peptide in hyperthyroidism. Clin Chem Acta 205:181-186, 1992.
261. Rich C, Bierman EL, Schwartz IL: Plasma nonesterified fatty acids in hyperthyroid states. J Clin Invest 38:275-278, 1959.
262. Amino N, Kuro R, Yabu Y, al. e: Elevated levels of circulating carcinoembryonic antigen in hypothyroidism. J Clin Endocrinol Metab 52:457-462, 1981.
263. Tucci JR, Kopp L: Urinary cyclic nucleotide levels in patients with hyper- and hypothyroidism. J Clin Endocrinol Metab 43:1323-1329, 1976.
264. Guttler RB, Shaw JW, Otis CL, Nicoloff JT: Epinephrine-induced alterations in urinary cyclic AMP in hyper- and hypothyroidism. J Clin Endocrinol Metab 41:707-711, 1975.
265. MacFarlane S, Papadopoulos S, Harden RM, Alexander WD: 131I and MIT-131I in human urine, saliva and gastric juice: A comparison between euthyroid and thyrotoxic patients. J Nucl Med 9:181-186, 1968.
266. Hellström K, Schuberth J: The effect of thyroid hormones on the urinary excretion of taurine in man. Acta Med Scand 187:61-65, 1970.
267. Maebashi M, Kawamura N, Sato M, al. e: Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism: Augmentation by thyroid hormone. Metabolism 26:351-356, 1977.
268. Levine RJ, Oates JA, Vendsalu A, Sjoerdsma A: Studies on the metabolism of aromatic amines in relation to altered thyroid function in man. J Clin Endocrinol Metab 22:1242-1250, 1962.
269. Copinschi G, Leclercq R, Bruno OD, Cornil A: Effects of altered thyroid function upon cortisol secretion in man. Horm Metab Res 3:437-442, 1971.
270. Harvey RD, McHardy KC, Reid IW, et al: Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J Clin Endocrinol Metab 72:1189-1194, 1991.
271. Kivirikko KI, Laitinen O, Lamberg BA: Value of urine and serum hydroxyproline in the diagnosis of thyroid disease. J Clin Endocrinol Metab 25:1347-1352, 1965.
272. Askenasi R, Demeester-Mirkine N: Urinary excretion of hydroxylysyl glycosides and thyroid function. J Clin Endocrinol Metab 40:342-344, 1975.
273. Golden AWG, Bateman D, Torr S: Red cell sodium in hyperthyroidism. Br Med J 2:552-554, 1971.
274. Weinstein M, Sartorio G, Stalldecker GB, al. e: Red cell zinc in thyroid dysfunction. Acta Endocrinol 20:147-152, 1972.
275. Pearson HA, Druyan R: Erythrocyte glucose-6-phosphate dehydrogenase activity related to thyroid activity. J Lab Clin Med 57:343-349, 1961.
276. Vuopio P, Viherkoski M, Nikkilä E, Lamberg BA: The content of reduced glutathione (GSH) in the red blood cells in hypo- and hyperthyroidism. Ann Clin Res 2:184-186, 1970.
277. Kiso Y, Yoshida K, Kaise K, et al: Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months. J Clin Endocrinol Metab 72:515-518, 1991.
278. Dube MP, Davis FB, Davis PJ, al. e: Effects of hyperthyroidism and hypothyroidism on human red blood cells Ca2+-ATPase activity. J Clin Endocrinol Metab 62:253-257, 1986.
279. Gwinup G, Ogundip O: Decreased leukocyte alkaline phosphatase in hyperthyroidism. Metabolism 62:253-257, 1974.
280. Jemelin M, Frei J, Scazziga B: Production of ATP in leukocyte mitochondria from hyperthyroid patients before and after treatment with a ß-adrenergic blocker and antithyroid drugs. Acta Endocrinol 66:606-610, 1971.
281. Strickland AL: Sweat electrolytes in thyroid disorders. J Pediatr 82:284-286, 1973.
282. Goolamali SK, Evered D, Shuster S: Thyroid disease and sebaceous function. Br Med J 1:432-433, 1976.
283. Christensen J, Schedl HP, Clifton JA: The basic electrical rhythm of the dudodenum in normal human subjects and in patients with thyroid disease. J Clin Invest 43:1659-1667, 1964.
284. Levy G, MacGillivray MH, Procknal JA: Riboflavin absorption in children with thyroid disorders. Pediatrics 50:896-900, 1972.
285. Singhelakis P, Alevizaki CC, Ikkos DG: Intestinal calcium absorption in hyperthyroidism. Metabolism 23:311-321, 1974.
286. Thomas FB, Caldwell JH, Greenberger NJ: Steatorrhea in thyrotoxicosis: Relation to hypermotility and excessive dietary fat. Ann Intern Med 78:669-675, 1973.
287. Wegener M, Wedmann B, Langhoff T, Schaffstein J, Adamek R: Effect of hyperthyroidism on the transport of a solid-liquid meal through the stomach, intestine, and the colon in man. J Clin Endocrinol Metab 75:745-749, 1992.
288. Scherrer M, König MP: Pulmonary gas exchange in hypothyroidism. Pneumonologie 151:105-113, 1974.
289. Zwillich CW, Pierson DJ, Hofeldt FD, et al: Ventilatory control in myxedema and hypothyroidism. N Engl J Med 292:662-665, 1975.
290. Lawson JD: The free Achilles reflex in hypothyroidism and hyperthyroidism. N Engl J Med 259:761-764, 1958.
291. Hall R, Owen SG: Thyroid antibodies in cerebrospinal fluid. Br Med J 2:710-711, 1960.
292. Hoffman I, Lowrey RD: The electrocardiogram in thyrotoxicosis. Am J Cardiol 6:893-904, 1960.
293. Lee JK, Lewis JA: Myxoedema with complete A-V block and Adams-Stokes disease abolished with thyroid medication. Br Heart J 24:253-265, 1962.
294. Wilkins L: Epiphysial dysgenesis associated with hypothyroidism. Am J Dis Child 61:13-34, 1941.
295. Bonakdarpour A, Kirkpatrick JA, Renzi A, Kendall N: Skeletal changes in neonatal thyrotoxicosis. Radiology 102:149-150, 1972.
296. Mariotti S, Anelli S, Ruf J, Bechi R, Czarnocka B, Lombardi A: Comparison of serum thyroid microsomal and thyroid peroxidase autoantibodies in thyroid diseases*. J Clin Endocrinol Metab 65:987-993, 1987.
297. Portmann L, Hamada N, Neinrich G, DeGroot LJ: Antithyroid peroxidase antibody in patients with autoimmune thyroid disease: Possible identity with anti-microsomal antibody. J Clin Endocrinol Metab 61:1001-1003, 1985.
298. Rinke R, Seto P, Rapoport B: Evidence for the highly conformational nature of the epitope(s) on human thyroid peroxidase that are recognized by sera from patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 71:53, 1990.
299. Kaufman KD, Filetti S, Seto P, Rapoport B: Recombinant human thyroid peroxidase generated in eukaryotic cells: A source of specific antigen for the immunological assay of antimicrosomal antibodies in the sera of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 70:724-728, 1990.
299a Chang CC, Huang CN, Chuang LM. Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur J Endocrinol 139:44-48, 1998
299b Smyth PP, Shering SG, Kilbane MT et al. Serum thryoid peroxidase antibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711-2716, 1998
300. Trotter WR, Belyavin G, Waddams A: Precipitating and complement fixing antibodies in Hashimoto's disease. Proc R Soc Med 50:961-962, 1957.
301. Boyden SV: The adsorption of proteins on erythrocytes treated with tannic acid and subsequent hemagglutination by antiprotein sera. J Exp Med 93:107-120, 1951.
302. Holborrow EJ, Brown PC, Roitt IM, Doniach D: Cytoplasmic localization of complement-fixing auto-antigen in human thyroid epithelium. Br J Exp Pathol 40:583-588, 1959.
303. Hamada N, Jaeduck N, Portmann L, al. e: Antibodies against denatured and reduced thyroid microsomal antigen in autoimmune thyroid disease. J Clin Endocrinol Metab 64:230-238, 1987.
304. Mori T, Kriss JP: Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab 33:688-698, 1971.
305. Mariotti S, Pinchera A, Vitti P, al. e: Comparison of radioassay and haemagglutionation methods for anti-thyroid microsomal antibodies. Clin Exp Immunol 34:118-125, 1978.
305a Miles J, Charles P, Riches P. A review of methods available for the identification of both organ-specific and non-organ-specific autoantibodies. Ann Clin Biochem: 35:19-47, 1998
306. Amino N, Hagen SR, Yamada N, Refetoff S: Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: Its usefulness in the diagnosis of autoimmune thyroid disease. Clin Endocrinol 5:115, 1976.
307. Ohtaki S, Endo Y, Horinouchi K, al. e: Circulating thyroglobulin-antithyroglobulin immune complex in thyroid diseases using enzyme-linked immunoassays. J Clin Endocrinol Metab 52:239-246, 1981.
308. Miles J, Charles P, Riches P: A review of methods available for the identification of both organ-specific and non-organ-specific autoantibodies. Ann Clin Biochem 35:19-47, 1998.
309. Feldt-Rasmussen U: Analytical and clinical performance goals for testing autoantobodies to thyroperoxidase, thyroglobulin, and thryotropin receptor. Clin Chem 42:160-63, 1996.
310. Loeb PB, Drash AL, Kenny FM: Prevalence of low-titer and "negative" antithyroglobulin antibodies in biopsy-proved juvenile Hashimoto's thyroiditis. J Pediatr 82:17-21, 1973.
311. Tamaki H, Katsumaru H, Amino N, Nakamoto H, Ishikawa E, Miyai K: Usefulness of thyroglobulin antibody detected by ultrasensitive enzyme immunoassay: A good parameter for immune surveillance in healthy subjects and for prediction of post-partum thyroid dysfunction. Clin Endocrinol (Oxf) 37:266-273, 1992.
312. Volpé R, Row VV, Ezrin C: Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab 27:1275-1284, 1967.
313. Balfour BM, Doniach D, Roitt IM, Couchman KG: Fluorescent antibody studies in human thyroiditis: Auto-antibodies to an antigen of the thyroid distinct from thyroglobulin. Br J Exp Pathol 42:307-316, 1961.
314. Staeheli V, Vallotton MB, Burger A: Detection of human anti-thyroxine and anti-triiodothyronine antibodies in different thyroid conditions. J Clin Endocrinol Metab 41:669-675, 1975.
315. Bastenie PA, Bonnyns M, Vanhaelst L, Nève P: Diseases associated with autoimmune thyroiditis. P. A. Bastenie and A. Ermans (eds), Thyroiditis and Thyroid Function., Pergamon Press, Oxford, pp. 1972.
317. Gupta MK: Thyrotropin receptor antibodies: Advances and importance of detection techniques in thyroid disease. Clin Biochem 25:193-199, 1992.
318. McKenzie JM: The bioassay of thyrotropin in serum. Endocrinology 63:372-381, 1958.
319. Furth ED, Rathbun M, Posillico J: A modified bioassay for the long-acting thyroid stimulator (LATS). Endocrinology 85:592-593, 1969.
320. Kriss JP, Pleshakov V, Rosenblum AL, al. e: Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab 27:582-593, 1967.
321. Sunshine P, Kusumoto H, Kriss JP: Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: Implications for diagnosis and therapy of the disorder. Pediatrics 36:869-876, 1965.
322. Onaya T, Kotani M, Yamada T, Ochi Y: New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices. J Clin Endocrinol Metab 36:859-866, 1973.
323. Hinds WE, Takai N, Rapoport B, al. e: Thyroid-stimulating activity and clinical state in antithyroid treatment of juvenile Graves' disease. Acta Endocrinol 94:46-52, 1981.
324. Leedman PJ, Frauman AG, Colman PG, Michelangeli VP: Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: A viable alternative to radioimmunoassay for the measurement of cAMP. Clin Endocrinol (Oxf) 37:493-499, 1992.
325. Takata I, Suzuki Y, Saida K, Sato T: Human thyroid-stimulating activity and clinical state in antithyroid treatment of juvenile Graves' disease. Acta Endocrinol 94:46-52, 1980.
326. Kendall-Taylor P, Atkinson S: A biological method for the assay of TSAb in serum. J. R. Stockigt and S. Nagataki (eds), Thyroid Research VIII, Australian Academy of Science, Canberra, pp. 763,1980.
327. Petersen V, Rees Smith B, Hall R: A study of thyroid-stimulating activity in human serum with the highly sensitive cytochemical bioassay. J Clin Endocrinol Metab 41:199-202, 1975.
328. Libert F, Lefort A, Gerard C, et al: Cloning, sequencing and expression of the human thyrotropin (TSH) receptors: Evidence for binding of autoantibodies. Biochem Biophys Res Commun 165:1250-1255, 1989.
329. Nagayama Y, Kaufman KD, Seto P, Rapoport B: Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor. Biochem Biophys Res Commun 165:1184-1190, 1989.
330. Ludgate M, Perret J, Parmentier M, et al: Use of the recombinant human thyrotropin receptor (TRHr) expressed in mammalian cell lines to assay TSHr autoantibodies. Mol Cell Endocrinol 73:R13-R18, 1990.
331. Filetti S, Foti D, Costante G, Rapoport. B: Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor antibodies. J Clin Endocrinol Metab 72:1096-1101, 1991.
331a Botero D, Brown RS. Bioassay of TSH receptor antibodies with Chinese hamster ovary cells transfected with recombinant human TSH receptor: clinical utility in children and adolescents with Graves' disease. J Pediatr 132:612-618, 1998
332. Vitti P, Elisei R, Tonacchera M, et al: Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. J Clin Endocrinol Metab 76:499-503, 1993.
333. Adams DD, Kennedy TH: Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland. J Clin Endocrinol Metab 27:173-177, 1967.
334. Shishiba Y, Shimizu T, Yoshimura S, Shizume K: Direct evidence for human thyroidal stimulation by LATS-protector. J Clin Endocrinol Metab 36:517-521, 1973.
335. Rapoport B, Greenspan FS, Filetti S, Pepitone M: Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulins. J Clin Endocrinol Metab 58:332-338, 1984.
336. Smith BR, Hall R: Thyroid-stimulating immunoglobulins in Graves' disease. Lancet 2:427-431, 1974.
337. Zakarija M, McKenzie JM, Munro DS: Evidence of an IgG inhibitor of thyroid-stimulating antibody (TSAb) as a cause of delay in the onset of neonatal Graves' disease. J Clin Invest 72:1352-1356, 1983.
338. Shewring G, Smith BR: An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol 17:409-417, 1982.
339. Endo K, Amir SM, Ingbar SH: Development and evaluation of a method for the partial purification of immunoglobulin specific for Graves' disease. J Clin Endocrinol Metab 52:1113-1123, 981.
340. Kosugi S, Ban T, Akamizu T, Konh LD: Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid stimulation antibodies and with thyroid stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptor. 6:166-180, 1992.
341. Drexhage HA, Bottazzo GF, Doniach D: Thyroid growth stimulating and blocking immunoglobulins. J. Chayen and L. Bitensky (eds), Cytochemical Bioassays, Marcel Dekker, New York, pp. 153,1983.
342. Valente WA, Vitti P, Rotella CM, al. e: Autoantibodies that promote thyroid growth: A distinct population of thyroid stimulating antibodies. N Engl J Med 309:1028-1034, 1983.
343. Grove AS Jr.: Evaluation of exophthalmos. N Engl J Med 292:1005-1013, 1975.
344. Parma J, Duprez L, van Sande J, et al: Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651, 1993.
345. Duprez L, Parma J, Van Sande J, et al: Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genet 7:396-401, 1994.
346. McKenzie JM, Zakarija M: Fetal and neonatal hyper- and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2:155-159, 1992.
347. Cho Y, Shong MH, Yi KH, Lee HK, Koh S, Min HK: Evaluation of serum basal thyrotrophin levels and thyrotrophin receptor antibody activities as prognostic markers for discontinuation of antithyroid drug treatment in patients with Graves' disease. Clin Endocrinol (Oxf) 36:585-590, 1992.
348. Hershman JM: Hyperthyroidism induced by trophoblastic thyrotropin. Mayo Clin Proc 47:913-918, 1972.
350. Nisula BC, Ketelslegers JM: Thyroid-stimulating activity and chorionic gonadotropin. J Clin Invest 54:494-499, 1974.
351. Bahn R, Heufelder AE: Pathogenesis of Graves' ophthalmopathy. New Engl J Med 329:1468-75, 1993.
352. Miller A, Arthurs B, Boucher A, al.e:Significance of antibodies reactive with a 64kDa eye muscle membrane antigen in patients with thryoid autoimmunity. Thyroid 2:197-202, 1992.
353. Winand RJ, Kohn LD: Stimulation of adenylate cyclase activity in retro-orbital tissue membranes by thyrotropin and an exophthalmogenic factor derived from thyrotropin. J Biol Chem 250:6522-6526, 1975.
354. Kodama K, Sikorka H, Bandy-Dafoe P, al. e: Demonstration of a circulating antibody against a soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet 2:1353-1356, 1982.
354a Matsuoka N, Eguchi K, Kawakami A et al. Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. J Clin Endocrinol Metab 81:4137-4143, 1996
354b Otto EA, Ochs K, Hansen C, Wall JR, Kahaly GJ. Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab 81:3045-50, 1996
355. Ryo UY, Arnold J, Colman M, al. e: Thyroid scintigram: Sensitivity with sodium pertechnetate Tc 99m and gamma camera with pinhole collimator. JAMA 235:1235-1238, 1976.
356. Atkins HL, Klopper JF, Lambrecht RM, Wolf AP: A comparison of technetium 99m and iodine 123 for thyroid imaging. Am J Roentgenol Radium Ther Nucl Med 117:195-201, 1973.
357. Nishiyama H, Sodd VJ, Berke RA, Saenger EL: Evaluation of clinical value of 123I and 131I in thyroid disease. J Nucl Med 15:261-265, 1974.
358. Tong ECK, Rubenfeld S: Scan measurements of normal and enlarged thyroid glands. Am J Roentgenol Radium Ther Nucl Med 115:706-708, 1972.
359. Mazzaferri EL: Management of a solitary thyroid nodule. New Engl J Med 328:553-9, 1993.
360. Becker FO, Economou PG, Schwartz TB: The occurrence of carcinoma in "hot" thyroid nodules: Report of two cases. Ann Intern Med 58:877-882, 1963.
361. Ashcraft MW, Van Herle AJ: Management of thyroid nodules I. History and physical examination, blood tests, x-ray tests and ultrasonography. Head Neck Surg 3:2l6-30, 1981.
362. Ladenson PW, Braverman LE, Mazzaferri EL, al. e: Comparison of administration of recombinant human thyrotropin with withdrawal of thryoid hormone for radioactive iodine scanning in patients with thyroid carcinoma. New Engl J Med 337:888-96, 1997.
363. Chen JJS, LaFrance ND, Allo MD, Cooper DS, Ladenson PWJ: Single photon emission computed tomography of the thyroid. J Clin Endocrinol Metab 66:1240-, 1988.
364. Corstens F, Huysmans D, Kloppenborg P: Thallium-210 scintigraphy of the suppressed thyroid: An alternative for iodine-123 scanning after TSH stimulation. J Nucl Med 29:1360-1363, 1988.
365. Fairweather DS, Bradwell AR, Watson-James SF, Dykes PW, Chandler S, Hoffenberg R: Deletion of thyroid tumours using radiolabeled thyroglobulin. Clin Endocrinol 18:563-570, 1983.
368. Barki Y: Ultrasonographic evaluation of neck masses-sonographic pattern in differential diagnosis. Isr J Med Sci 28:212-216, 1992.
369. Watters DAK, Ahuja AT, Evans RM, et al: Role of ultrasound in the management of thyroid nodules. Am J Surg 164:654-657, 1992.
370. Scheible W, Leopold GR, Woo VL, Gosink BB: High resolution real-time ultrasonography of thyroid nodules. Radiology 133:413-417, 1979.
371. Sostre S, Reyes MM: Sonographic diagnosis and grading of Hashimoto's thyroiditis. J Endocrinol Invest 14:115-121, 1991.
372. Brander A, Viikinkoski P, Nickels J, Kivisaari L: Thyroid Gland: US screening in a random adult population. Radiol 181:683-687, 1991.
373. Danese D, Sciacchitano S, Farsetti A al. e: Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thryoid nodules. Thyroid 8:15-21, 1998.
374. Szebeni A, Beleznay EJ: New simple method for thyroid volume determination by ultrasonography. Clin Ultrasound 20:329-337, 1992.
375. Jarlov AE, Hegedus L, Gjorup T, Hansen JEM: Accuracy of the clinical assessment of thyroid size. Dan Med Bull 38:87-89, 1991.
376. Paracchi A, Ferrari C, Livraghi T, et al: Percutaneous intranodular ethanol injection: A new treatment for autonomous thyroid adenoma. J Endocrinol Invest 15:353-362, 1992.
378. Blum M, Reede DL, Seltzer TF, Burroughs VJ: Computerized axial tomography in the diagosis of thyroid and parathyroid disorders. Am J Med Sci 287:34-39, 1984.
379. Brown LR, Aughenbaugh GL: Masses of the anterior mediastinum: CT and MR imaging. Amer J Radiol 157:1171-1180, 1991.
380. Gittoes NJL, Miller MR, Daykin J, Sheppard MC, Franklyn JA: Upper airways obstruction in patients presenting with thyroid enlargement. Br Med J 312:484, 1996.
384. Wang C, Vickery AL Jr., Maloof F: Needle biopsy of the thyroid. Surg Gynecol Obstet 143:365-368, 1976.
385. Ashcraft MW, Van Herle AJ: Management of thyroid suppressive therapy, and fine needle aspiration. Head and Neck Surgery 3:297-322, 1981.
388. Matos-Godilho L, Kocjan G, Kurtz A: Contribution of fine needle aspiration cytology to diagnosis and management of thyroid disease. J Clin Path 45:391-395, 1992.
388a Franklyn JA, Daykin J, Young J et al. Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules. Br Med J 307:240-1, 1993
388b Mazzaferri El. Management of a solitary thyroid nodule. New Engl J Med 328:553-9, 1993
389. Hamberger B, Gharib H, Melton LJ 3rd, al. e: Fine-needle aspiration biopsy of thyroid nodules: Impact on thyroid practice and cost of care. Am J Med 73:381-384, 1982.
389a Bennedbaek FN, Karstrup S, Hegedus L: Percutaneous ethanol injection therapy in the treatment of thyroid and parathyroid diseases. Eur J Endocrinol 136:240-50, 1997.
390. Odell WD, Wilber FJ, Utiger RD: Studies on thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res 23:47-85, 1967.
391. Jackson IMD: Thyrotropin-releasing hormone. N Engl J Med 306:145-155, 1982.
397. Beck-Peccoz P, Amr S, Menezes-Ferreira M, al. e: Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropin-releasing hormone. J Clin Endocrinol Metab 312:1085-1090, 1985.
399. Pierce JG: The subunits of pituitary thyrotropin: Their relation to other glycoprotein hormones. Endocrinology 89:1331-1344, 1971.
401. Miyai K, Fukuchi M, Kumahara Y: Correlation between biological and immunological potencies of human serum and pituitary thyrotropin. J Clin Endocrinol Metab 29:1438-1442, 1969.
402. Gendrel D, Feinstein MC, Grenier J, al. e: Falsely elevated serum thyrotropin (TSH) in newborn infants: Transfer from mothers to infants of a factor interfering in the TSH radioimmunoassay. J Clin Endocrinol Metab 52:62-65, 1981.
403. Chaussain JL, Binet E, Job JC: Antibodies to human thyreotrophin in the serum of certain hypopituitary dwarfs. Rev Eur Etud Clin Biol 17:95-99, 1972.
404. Nicoloff JT, Spencer CA: The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 71:553-558, 1990.
405. Kricka LJ: Chemiluminescent and bioluminescent techniques. Clin Chem 37:1472-1481, 1991.
406. Spencer CA, Schwarzbein D, Guttler RB, LoPresti JS, Nicoloff JT: Thyrotropin-releasing hormone stimulation test responses employing third and fourth generation TSH assays. J Clin Endocrinol Metab 76: 494-98, 1993.
407. Spencer CA, Takeuchi M, Kazarosyan M al. e: Interlaboratory differences in functional sensitivity of immunometric assays of thryotropin and impact on relaibility of measurement of subnormal concnetrations of TSH. Clin Chem 41: 367-74, 1995.
408. Spencer CA, Takeuchi M, Kazarosyan M: Current status and performance goals for serum TSH assays. Clin Chem 42:140-45, 1996.
409. Brennan MD, Klee GG, Preissner CM, Hay ID: Heterophilic serum antibodies: A cause for falsely elevated serum thyrotropin levels. Mayo Clin Proc 62:894-898, 1987.
410. Wood JM, Gordon DL, Rudinger AN, Brooks MM: Artifactual elevation of thyroid-stimulating hormone. Amer J Med 90:261-262, 1991.
411. Zweig MH, Csako G, Reynolds JC, Carrasquillo JA: Interference by iatrogenically induced anti-mouse IgG antibodies in a two-site immunometric assay for thyrotropin. Arch Path Rad Metab 1165:164-168, 1991.
412. Kourides IA, Heath CV, Ginsberg-Fellner F: Measurement of thyroid-stimulating hormone in human amniotic fluid. J Clin Endocrinol Metab 54:635-637, 1982.
413. Fisher DA, Kleinm AH: Thyroid development and disorders of thyroid function in the newborn. N Engl J Med 304:702-712, 1981.
414. Snyder PJ, Utiger RD: Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab 34:380-385, 1972.
415. Hershman JM, Pittman JA Jr.: Utility of the radioimmunoassay of serum thyrotrophin in man. Ann Intern Med 74:481-490, 1971.
416. Brabant G, Prank K, Ranft U, et al: Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J Clin Endocrinol Metab 70:403-409, 1990.
417. Bartalena L, Martino E, Falcone M, et al: Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders. J Clin Endocrinol Metab 65:1265-1271, 1987.
418. Ria AG, Brabant K, Prank E, Endert E, Wiersinga WM: Circadian changes in pulsatile TSH release in primary hypothyroidism. Clin Endocrinol 37:504-510, 1992.
419. Brabant G, Prank C, Hoang-Vu C, Hesch RD, von zur Muhlen A: Hypothalamic regulation of pulsatile thyrotropin secretion. J Clin Endocrinol Metab 72:145-150, 1991.
420. Romijn JA, Adriaanse G, Brabant K, Prank E, Endert E, Wiersinga WM: Pulsatile secretion of thyrotropin during fasting: A decrease of thyrotropin pulse amplitude. J Clin Endocrinol Metab 70:1631-1636, 1990.
421. Bartalena L, Pacchiarotti A, Palla R, et al: Lack of nocturnal serum thyrotropin (TSH) surge in patients with chronic renal failure undergoing regular maintenance hemofiltration: A case of central hypothyroidism. Clin Nephrol 34:30-34, 1990.
422. Romijn JA, Wiersinga WM: Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab 70:35-42, 1990.
423. Van Cauter E, Golstein J, Vanhaelst L, Leclercq R: Effects of oral contraceptive therapy on the circadian patterns of cortisol and thyrotropin (TSH). Eur J Clin Invest 5:115-121, 1975.
424. Brabant G, Brabant A, Ranft U, et al: Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration. J Clin Endocrinol Metab 65:83-88, 1987.
425. Simoni M, Velardo A, Montanini V, Faustini Fustini M, Seghedoni S, Marrama P: Circannual rhythm of plasma thyrotropin in middle-aged and old euthyroid subjects. Horm Res 33:184-189, 1990.
426. Wilber JF, Baum D: Elevation of plasma TSH during surgical hypothermia. J Clin Endocrinol Metab 31:372-375, 1970.
427. Vagenakis AG, Rapoport B, Azizi F, al. e: Hyper-response to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentration. J Clin Invest 54:913-918, 1974.
428. Snyder PJ, Utiger RD: Inhibition of thyrotropin response to thyrotropin releasing hormone by small quantities of thyroid hormones. J Clin Invest 51:2077-2084, 1972.
429. Ehrmann DA, Weinberg M, Sarne DH: Limitations to the use of a sensitive assay for serum thyrotropin in the assessment of thyroid status. Arch Intern Med 149:369-372, 1989.
430. Ridgway EC, Cooper DS, Walker H, al. e: Peripheral responses of thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab 53:1238-1242, 1981.
431. Aizawa T, Koizumi Y, Yamada T, al. e: Difference in pituitary-thyroid feedback regulation in hypothyroid patients, depending on the severity of hypothyroidism. J Clin Endocrinol Metab 47:560-565, 1978.
432. Spencer CA: Clinical utility and cost-effectiveness of sensitive thyrotropin assays in ambulatory and hospitalized patients. Mayo Clin Proc 63:1214-1222, 1988.
433. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH: American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 263:1529-1532, 1990.
434. Delange F, Dodion J, Wolter R, al. e: Transient hypothyroidism in the newborn infant. J Pediatr 92:974-976, 1978.
435. Brown ME, Refetoff S: Transient elevation of serum thyroid hormone concentration after initiation of replacement therapy in myxedema. Ann Intern Med 92:491-495, 1980.
436. Sanchez-Franco F, Cacicedo GL, Martin-Zurro A, al. e: Transient lack of thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in treated hyperthyroid patients with normal or low serum thyroxine (T4) and triiodothyronine (T3). J Clin Endocrinol Metab 38:1098-1102, 1974.
437. Spencer CA, Elgen A, Shen D, et al: Specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 33:1301-1396, 1987.
438. Sunthornthepvarakul T, Gottschalk ME, Hayashi Y, Refetoff S: Resistance to thyrotropin caused by mutations in the thyrotropin receptor gene. N Engl J Med 332:(in press), 1995.
439. Weintraub BD, Gershengorn MC, Kourides IA, Fein H: Inappropriate secretion of thyroid stimulating hormone. Ann Intern Med 95:339-351, 1981.
440. Mihailovic V, Feller MS, Kourides IA, Utiger RD: Hyperthyroidism due to excess thyrotropin secretion: Follow-up studies. J Clin Endocrinol Metab 50:1135-1138, 1980.
441. Kourides IA, Ridgway EC, Weintraub BD, al. e: Thyrotropin-induced hyperthyroidism: Use of alpha and beta subunit levels to identify patients with pituitary tumors. J Clin Endocrinol Metab 45:534-543, 1977.
442. Sarne DH, Sobieszczyk S, Ain KB, Refetoff S: Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: Responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression. J Clin Endocrinol Metab 70:1305-1311, 1990.
443. Brent GA, Hershman JM, Braunstein GD: Patients with severe nonthyroidal illness and serum thyrotropin concentrations in the hypothyroid range. Am J Med 81:463-466, 1986.
444. Topliss DJ, White EL, Stockigt JR: Significance of thyrotropin excess in untreated primary adrenal insufficiency. J Clin Endocrinol Metab 50:52-56, 1980.
445. Wehmann RE, Gregerman RI, Burns WH, al. e: Suppression of thyrotropin in the low-thyroxine state of severe nonthyroidal illness. N Engl J Med 312:546-552, 1985.
446. Bacci V, Schussler GC, Kaplan TB: The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab 54:1229-1235, 1982.
447. Kourides IA, Weintraub BD, Ridgway EC, Maloof F: Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders. J Clin Endocrinol Metab 40:872-885, 1975.
448. Oliver C, Charvet JP, Codaccioni J-L, Vague J: Radioimmunoassay of thyrotropin-releasing hormone (TRH) in human plasma and urine. 39:406-410, 1974.
449. Emerson CH, Frohman LA, Szabo M, Thakker I: TRH immunoreactivity in human urine: Evidence for dissociation from TRH. 45:392-399, 1977.
450. Mitsuma T, Hiraoka Y, Nihei N: Radioimmunoassay of thyrotropin-releasing hormone in human serum and its application. 83:225-, 1976.
451. Mallik TK, Wilber JF, Pegues J: Measurements of thyrotropin-releasing hormone-like material in human peripheral blood by affinity chromatography and radioimmunoassay. 54:1194-1198, 1982.
452. Weeke J: The influence of the circadian thyrotropin rhythm on the thyrotropin response to thyrotropin-releasing hormone in normal subjects. Scand J Clin Lab Invest 33:17-20, 1974.
453. Haigler ED Jr., Hershman JM, Pittman JA Jr., Blaugh CM: Direct evaluation of pituitary thyrotropin reserve utilizing thyrotropin releasing hormone. J Clin Endocrinol Metab 33:573-581, 1971.
454. Azizi F, Vagenakis AG, Portnay GE, al. e: Pituitary-thyroid responsiveness to intramuscular thyrotropin-releasing hormone based on analyses of serum thyroxine, tri-iodothyronine and thyrotropin concentration. N Engl J Med 292:273-277, 1975.
455. Haigler ED Jr., Hershman JM, Pittman JA Jr.: Response to orally administerd synthetic thyrotropin-releasing hormone in man. J Clin Endocrinol Metab 35:631-635, 1972.
456. Ormston BJ, Kilborn JR, Garry R, al. e: Further observations on the effect of synthetic thyrotrophin-releasing hormone in man. Br Med J 2:199-202, 1971.
457. Hershman JM, Kojima A, Friesen HG: Effect of thyrotropin-releasing hormone on human pituitary thyrotropin, prolactin, placental lactogen, and chorionic thyrotropin. J Clin Endocrinol Metab 36:497-501, 1973.
458. Jacobsen BB, Andersen H, Dige-Petersen H, Hummer L: Thyrotropin response to thyrotropin-releasing hormone in fullterm, euthyroid and hypothyroid newborns. Acta Paediatr Scand 65:433-438, 1976.
459. Sanchez-Franco F, Garcia MD, Cacicedo L, al. e: Influence of sex phase of the menstrual cycle on thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH). J Clin Endocrinol Metab 37:736-740, 1973.
460. Harman SM, Wehmann RE, Blackman MR: Pituitary-thyroid hormone economy in healthy aging men:Basal indices of thyroid function and thyrotropin responses to constant infusions of thyrotropin releasing hormone. J Clin Endocrinol Metab 58:320-326, 1984.
461. Wilber J, Jaffer A, Jacobs L, al. e: Inhibition of thyrotropin releasing hormone (TRH) stimulated thyrotropin (TSH) secretion in man by a single oral dose of thyroid hormone. Horm Metab Res 4:508, 1972.
462. Wartofsky L, Dimond RC, Noel GL, al. e: Effect of acute increases in serum triiodothyronine on TSH and prolactin responses to TRH, and estimates of pituitary stores of TSH and prolactin in normal subjects and in patients with primary hypothyroidism. J Clin Endocrinol Metab 42:443-458, 1976.
463. Shenkman L, Mitsuma T, Suphavai A, Hollander CS: Triiodothyronine and thyroid-stimulating hormone response to thyrotrophin-releasing hormone: A new test of thyroidal and pituitary reserve. Lancet 1:111-113, 1972.
464. Anderson MS, Bowers CY, Kastin AJ, al. e: Synthetic thyrotropin-releasing hormone: A potent stimulator of thyrotropin secretion in man. N Engl J Med 285:1279-1283, 1971.
465. McFarland KF, Strickland AL, Metzger WT, Smith JS: Thyrotropin-releasing hormone test: An adverse reaction. Arch Intern Med 142:132-133, 1982.
466. Fleischer N, Lorente M, Kirkland J, al. e: Synthetic thyrotropin releasing factor as a test of pituitary thyrotropin reserve. J Clin Endocrinol Metab 34:617-624, 1972.
467. Sachson R, Rosen SW, Cuatrecasas P, al. e: Prolactin stimulation by thyrotropin-releasing hormone in a patient with isolated thyrotropin deficiency. N Engl J Med 287:972-973, 1972.
468. Vagenakis AG, Braverman LE, Azizi F, al. e: Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N Engl J Med 293:681-684, 1975.
469. Tamai H, Nakagawa T, Ohsako N, al. e: Changes in thyroid function in patients with euthyroid Graves' disease. J Clin Endocrinol Metab 50:108-112, 1980.
470. Tamai H, Suematsu H, Ikemi Y, al. e: Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease. J Clin Endocrinol Metab 47:475-479, 1978.
476. Werner SC, Spooner M: A new and simple test for hyperthyroidism employing L-triiodothyronine and the twenty-four hour I-131 uptake method. Bull NY Acad Med 31:137-145, 1955.
477. Duick DS, Stein RB, Warren DW, Nicoloff JT: The significance of partial suppressibility of serum thyroxine by triiodothyronine administration in euthyroid man. J Clin Endocrinol Metab 41:229-234, 1975.
480. Stanbury JB, Kassenaar AAH, Meijer JWA: The metabolism of iodotyrosines. I. The fate of mono- and di-iodotyrosine in normal subjects and in patients with various diseases. J Clin Endocrinol Metab 16:735-746, 1956.
481. Lissitzky S, Codaccioni JL, Bismuth J, Depieds R: Congenital goiter with hypothyroidism and iodo-serum albumin replacing thyroglobulin. J Clin Endocrinol Metab 27:185-196, 1967.
482. DeGroot LJ: Kinetic analysis of iodine metabolism. J Clin Endocrinol Metab 26:149-173, 1966.
483. Hays MT: Absorption of oral thyroxine in man. J Clin Endocrinol Metab 28:749-756, 1968.
484. Hays MT: Absorption of triiodothyronine in man. J Clin Endocrinol Metab 30:675-677, 1970.
485. Valente WA, Goldiner WH, Hamilton BP, al. e: Thyroid hormone levels after acute L-thyroxine loading in hypothyroidism. J Clin Endocrinol Metab 53:527-529, 1981.
486. Ain KB, Refetoff S, Fein HG, Weintraub BD: Pseudomalabsorption of levothyroxine. JAMA 266:2118-2120, 1991.
488. Oppenheimer JH, Schwartz HL, Surks MI: Determination of common parameters of iodothyronine metabolism and distribution in man by noncompartmental analysis. J Clin Endocrinol Metab 41:319-324, 1172-1173, 1975.
489. Curti GI, Fresco GF: A theoretical five-pool model to evaluate triiodothyronine distribution and metabolism in healthy subjects. Metabolism 41:3-10, 1992.
490. Bianchi R, Mariani G, Molea N, et al: Peripheral metabolism of thyroid hormones in man. I. Direct measurement of the conversion rate of thyroxine to 3, 5,3'-triiodothyronine (T3) and determination of the peripheral and thyroidal production of T3. J Clin Endocrinol Metab 56:1152-1163, 1983.
491. Faber J, Heaf J, Kirkegaard C, et al: Simultaneous turnover studies of thyroxine, 3,5,3'-and 3,3',5-triiodothyronine, and 3'-monoiodothyronine in chronic renal failure. J Clin Endocrinol Metab 56:211-217, 1983.
492. Refetoff S, Fang VS, Marshall JS, Robin NI: Metabolism of thyroxine-binding globulin (TBG) in man: Abnormal rate of synthesis in inherited TBG deficiency and excess. J Clin Invest 57:485-495, 1976.
493. Lim VS, Fang VS, Katz AI, Refetoff S: Thyroid dysfunction in chronic renal failure: A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest 60:522-534, 1977.
494. LoPresti JS, Warren DW, Kaptein EM, al. e: Urinary immunoprecipitation method for estimation of thyroxine and triiodothyronine conversion in altered thyroid states. J Clin Endocrinol Metab 55:666-670, 1982.
495. Ridgway EC, Weintraub BD, Maloof F: Metabolic clearance and production rates of human thyrotropin. J Clin Invest 895-903:1974.
496. Cuttelod S, Lemarchand-Beraud T, Magnenat P, al. e: Effect of age and role of kidneys and liver on thyrotropin turnover in man. Metabolism 23:101-113, 1974.
497. Cavalieri RR, Searle GL: The kinetics of distribution between plasma and liver of 131I-labeled L-thyroxine in man: Observations of subjects with normal and decreased serum thyroxine-binding globulin. J Clin Invest 45:939-949, 1966.
498. Oppenheimer JH, Bernstein G, Hasen J: Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131I and albumin-125I. J Clin Invest 46:762-777, 1967.